The text examines various financial statements for Raytheon Technologies Corporation, including the condensed consolidated statement of operations, comprehensive income (loss), balance sheet, cash flows, and changes in equity for the quarter and nine months ended September 30. It details the company's net sales, costs and expenses, income (loss) from continuing operations, assets, liabilities, equity, and cash flows, comparing 2021 and 2020 figures. Key information highlighted encompasses net income (loss), earnings per share, comprehensive income, key balances, and fundamental financial metrics. Furthermore, it addresses the impact of the adoption of Accounting Standards Update (ASU) 2016-13 on financial instruments, focusing on contract assets and liabilities, inventory, borrowings, long-term debt, and employee benefit plans like pension and postretirement plans. Detailed insights are provided on changes in contract assets and liabilities, inventory valuations, borrowings, long-term debt issuances and repayments, and adjustments to employee benefit plans due to separation transactions. The report notes figures for different periods and explains how various factors affected the company's financial standing as of September 30, 2021.
The text provides an overview of the financial condition and operations of a global systems provider to the aerospace and defense industries following corporate transactions, now operating under Raytheon Technologies Corporation with four principal businesses. It discusses various factors such as government regulations, COVID-19 impacts, and political conditions affecting operations, with the pandemic resulting in significant write-downs and adjustments in their aerospace divisions in 2020. The company expects continued impacts due to reduced air travel and future uncertainties like vaccination mandates, economic conditions, and political sanctions. The text also covers segment reviews, restructuring costs related to severance and facility exits, and significant EAC adjustments affecting net sales and operating profit for Collins Aerospace Systems amidst the pandemic.
There has been no significant change in the company's exposure to market risk during the nine months ended September 30, 2021. Additional details on their market risk exposure can be found in Part II, Item 7A of their 2020 Form 10-K.
The text discusses the evaluation of disclosure controls and procedures by management as of September 30, 2021, in compliance with Rule 13a-15 under the Exchange Act. It highlights the limitations of the system while stating that controls were effective in providing reasonable assurance for disclosure requirements. No significant changes in internal controls over financial reporting were reported. Moreover, the text includes a cautionary note on forward-looking statements, outlining various factors like economic conditions, acquisition activities, indebtedness, and legal proceedings that may impact future results. It emphasizes the risks and uncertainties associated with these factors and concludes with a disclaimer on the timing and need for periodic updates on forward-looking statements as per applicable law. Additional information on risks and factors affecting results is provided in specific sections of Form 10-Q and the Annual Report.

This comprehensive text touches on the evaluation of disclosure controls and procedures by management, the effectiveness of controls as of a specific date, potential changes in internal controls, and risks related to forward-looking statements and various factors that might affect future results. It also emphasizes the need for periodic updates and detailed information provided in specific sections of the filed reports for a comprehensive understanding of the risks and uncertainties.
The text indicates that, aside from the information provided in "Note 17: Commitments and Contingencies" in Item 1 of Form 10-Q regarding ongoing legal proceedings, there have been no significant updates in legal matters. For previous information on legal proceedings, reference should be made to Part I, Item 3, "Legal Proceedings," in the company's 2020 Annual Report on Form 10-K.
The text highlights the importance of reviewing certain risk factors that could significantly impact a business's operations, financial status, or future outcomes. It suggests referring to the information provided in the company's 2020 Annual Report on Form 10-K for details on these factors. While there have been no significant changes from the factors disclosed in the 2020 report, any updates or additional factors may be outlined in future filings with the Securities and Exchange Commission (SEC).
The issuer has provided information about their purchases of equity securities during the quarter ending September 30, 2021. They announced a share repurchase program for up to $5 billion of their common stock on December 7, 2020, replacing a previous program from October 14, 2015. The program allows for purchasing shares through various methods, subject to applicable law. During the mentioned quarter, they repurchased a total of 11,535 shares at an average price of $85.18 per share, with a remaining value of $2,998 million for potential repurchases under the program. No shares were repurchased outside of the program during this period.
Apologies for the confusion, but I haven't received any parts of the text you mentioned. Could you please provide the text you would like me to summarize?
I'm ready to help, please go ahead and provide me with the text that needs to be summarized.
I'm ready to assist you with summarizing the text. You can go ahead and provide me with the text that needs to be summarized.
The text provided is a legal disclosure related to filings under the Securities Exchange Act of 1934 for Raytheon Technologies Corporation. It includes various exhibits such as certifications, XBRL Instance Document, Taxonomy Extension Schema Documents, Cover Page Interactive Data File, and other financial statements. The document also includes signatures of Neil G. Mitchill, Jr. and Amy L. Johnson, representing the company as executive vice president, chief financial officer, corporate vice president, and controller. This filing was made on behalf of the Registrant as required by the Securities Exchange Act.
